Biotech China 2014

Biotechnology: Pfizer

Total Score People Score Events Score
28 28 13
Date Event Presentation Speakers
February 10, 2013 7thANNUAL DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE: An Intensive Course on Translating Research into Drugs Plenary: Transforming Drug Discovery for Complex Diseases: A Systems Biology Approac Piet Van Der Graaf
April 20, 2011 BayBio Annual Conference 2011 | Powering Global Innovation Track 1 Financial | Communicating Life Science Value Propositions Jim McLoughlin
April 6, 2010 IBCs 5th Annual China 2010 Pharmaceutical R&D Summit China's Pharmaceutical Industry from the Insiders' Eyes Steve Yang
Chairperson's Opening Remarks Steve Yang
4 Simultaneous Global Development - What Does It Mean for China? Bradley Merchant
An MNC's Perspective on the Overall Capabilities of China's Biosimilars/FOB Development - A Comparison with US/EU Yining Zhao
Martin Mackay, Ph.D. Right Targets. Right Patients. Right Now. Martin Mackay
October 6, 2009 Third Annual Improving Protein Expression Through Innovation Saving Time and Costs for Antibody Expression in Mammalian Cells Gerald Casperson
Therapeutic Antibody Production in Mammalian Cells at Lab Scale: Comparison, Adaptation and Implementation of Strategies for Time and Cost Savings Gerald Casperson
June 16, 2009 7th Annual Comparability for Biologics Developing and validating a whole blood cytokine release assay Aparna Deora
May 12, 2009 The 18th Annual EU Pharmaceutical Law Forum Update on the Paediatric Medicines Regulation Victoria Kitcatt
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Title: TBD :Track 2-3 Yuan-Hua Ding
May 7, 2008 Advances in Biodefense Technology Emerging Pathogens and Pathogen Biomarkers - Anthrax Amit Banerjee
November 12, 2007 Well Characterized Biologicals - Continuous Evolution of Chemo- and Bioanalytical Approaches Nov(12 - 14) Chairperson's Opening Remarks (08:00-08:15) Ned Mozier
Assessing Structure/Function Relationships (08:15-10:45) Aparna Deora
Assessing Structure/Function Relationships :Protein Changes that Make a Difference: Measuring the Impact on Biopotency with Various Bioanalytical Methods (09:15-09:45) Aparna Deora
Causes and Assessment of Product and Process-Related Impurities (13:25-18:30) Peter J. Nicastro
Causes and Assessment of Product and Process-Related Impurities:Comparison of Techniques for Aggregate Measurement (14:00-14:30) Peter J. Nicastro
CMC Approaches to Specific and Emerging Biotech Products (09:15-10:45) Michael R Schlittler,
CMC Approaches to Specific and Emerging Biotech Products: Characterization of Synthetic Peptides for Biotechnology - Unique Challenges (09:15-09:45) Michael R Schlittler,
Process and Analytical Related Issues (15:30-17:00) Amit Banerjee
September 30, 2007 BioProcess International Conference & Exhibition Pre-Conference Workshops A & B (13:30 - 17:00) Gerald F. Casperson
Pre-Conference Workshop B (13:00 - 17:00) Gerald F. Casperson
Pre-Conference Workshop B: Protein Production Via Large Scale Transient Transfection of Mammalian Cells Gerald F. Casperson
Production & Economics of Biopharmaceuticals, Strategies for Flexible Facility Design and Capacity Optimization (07:00 - 11:30) James Bouressa,
Strategies for Flexible Facility Design and Capacity Optimization : Optimizing the Use of a Multi-Product Biologics Clinical Manufacturing Facility James Bouressa,
Scaling Up from Bench through Commercialization , Best Practices for Strategic Scale Up Decisions (07:00 - 12:15) Ellen L. McCormick
Best Practices for Strategic Scale Up Decisions: CP-675,206: Manufacturing Strategy toward BLA/MAA Ellen L. McCormick
Scaling Up from Bench through Commercialization ; Regulatory and Quality Considerations (13:45 - 17:45) Thomas P. Garcia
Regulatory and Quality Considerations : Update on Experience with FDA Pilot Program Thomas P. Garcia
Market Forces and Technology Developments Affecting Economics of Biopharmaceuticals : Using Process Simulation to Prioritize Development Activities Joseph K. McLaughlin
Production & Economics of Biopharmaceuticals ; Market Forces and Technology Developments Affecting Economics of Biopharmaceuticals (08:00 - 11:30) Joseph K. McLaughlin
September 30, 2007 Bridging Pharma and IT - Leveraging Information Technology to Improve Productivity (Sep30-Oct2) BRIDGING DISCOVERY/DEVELOPMENT AND IT: An Integrated Desktop Computing Environment for Chemists (14:00-14:45) Daniel Ortwine, Robert Goulet
BRIDGING DISCOVERY/DEVELOPMENT AND IT (09:30-15:30) Julie Hughes, Daniel Ortwine, Robert Goulet
BRIDGING DISCOVERY/DEVELOPMENT AND IT: Developing of Enabling Informatics Technology in Support of the Development of Drug Candidates (09:30-10:15) Julie Hughes
BRIDGING DISCOVERY/DEVELOPMENT AND IT (10:45-15:15) Melinda Rottas, Peter F. Thadeio
BRIDGING DISCOVERY/DEVELOPMENT AND IT: One Company ~ 2 Worlds - Bridging Discovery and Development Information (10:45-11:30) Melinda Rottas, Peter F. Thadeio
September 26, 2007 EuroBio2007 (Sep 26th - 28th) BIOTECH ECONOMY AND BUSINESS DEVELOPMENT (09:00 - 18:30) Ruth Keir
BIOTECH ECONOMY AND BUSINESS DEVELOPMENT: What types of opportunities are pharmaceutical companies looking to invest in ? Biotech / Pharma: Case studies. (14:00 - 16:00) Ruth Keir
September 19, 2007 Drug Delivery Global Summit Successful Partnering in the Drug Delivery Market Place James Eshelby
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.